These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22227071)

  • 41. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.
    Jin HB; Gu ZY; Yu CH; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):389-92. PubMed ID: 16109522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re: Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    Erdem G; Ercin CN; Dogru T; Tasci I; Sonmez A
    Nutrition; 2009 Feb; 25(2):240. PubMed ID: 18947975
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum visfatin in nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Romiopoulos I; Polymerou V
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):150-1. PubMed ID: 24378279
    [No Abstract]   [Full Text] [Related]  

  • 44. Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis.
    Tankurt E; Biberoglu S; Ellidokuz E; Hekimsoy Z; Akpinar H; Cömlekçi A; Okan A; Sagol O
    J Hepatol; 1999 Nov; 31(5):963. PubMed ID: 10580597
    [No Abstract]   [Full Text] [Related]  

  • 45. [Serum dipeptidyl peptidase N levels in obese children with nonalcoholic fatty liver disease].
    Kan X; Liu GL; Han Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):865-6. PubMed ID: 23405399
    [No Abstract]   [Full Text] [Related]  

  • 46. [Adolescence, obesity, and the role of lipoprotein lipases in the non-alcoholic fatty liver disease].
    Pardina E; Peinado-Onsurbe J
    Endocrinol Nutr; 2012; 59(6):343-5. PubMed ID: 22658542
    [No Abstract]   [Full Text] [Related]  

  • 47. Fatty liver: cause or consequence.
    Hitman GA
    Diabet Med; 2012 Sep; 29(9):1097. PubMed ID: 22882641
    [No Abstract]   [Full Text] [Related]  

  • 48. [Visfatin--what is currently known about its role in physiology and pathology?].
    Cybulska B
    Kardiol Pol; 2011; 69(8):808-9. PubMed ID: 21850624
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical correlates of histopathology in non-obese non-alcoholic fatty liver disease].
    Jiang Y; Lou G; Xun Y; Liu H; Bian D; Qian J; Lu L; Shi J
    Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):380-2. PubMed ID: 25222974
    [No Abstract]   [Full Text] [Related]  

  • 50. Role of Fatty Liver, Dietary Fatty Acid Supplements, and Obesity in the Progression of Alcoholic Liver Disease. October 3, 2003, Bethesda, Maryland, USA. Proceedings of a meeting.
    Alcohol; 2004 Aug; 34(1):1-87. PubMed ID: 15670658
    [No Abstract]   [Full Text] [Related]  

  • 51. Correlation between latent diabetes mellitus, obesity and fatty liver.
    Knick B; Lange HJ; Heckmann K
    Ger Med Mon; 1966 Apr; 11(4):149-52. PubMed ID: 5931147
    [No Abstract]   [Full Text] [Related]  

  • 52. The concentration of vitamin B12 in serum correlates with the degree of fatty liver in morbidly obese patients.
    Nanji AA; French SW; Freeman JB
    Clin Chem; 1985 Nov; 31(11):1913. PubMed ID: 4053370
    [No Abstract]   [Full Text] [Related]  

  • 53. Asymptomatic obese adolescents: No coronary atherosclerosis?
    Tang Y; Li J; Su W; Bongo JB
    J Pediatr; 2013 Oct; 163(4):1232. PubMed ID: 23910687
    [No Abstract]   [Full Text] [Related]  

  • 54. [2nd prize in the competition of young scientists in the XVIII National Congress "Man and Medicine" of 2011].
    Andreev DN
    Eksp Klin Gastroenterol; 2011; (8):102-4. PubMed ID: 22629765
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of the diabetic state on selected mitochondrial reactions.
    BEYER RE; SHAMOIAN CA; ABEND MN
    Metabolism; 1962 Apr; 11():394-403. PubMed ID: 13868756
    [No Abstract]   [Full Text] [Related]  

  • 56. Reply: To PMID 23260104.
    Singh G; Magkos F; Klein S
    J Pediatr; 2013 Oct; 163(4):1233. PubMed ID: 23906979
    [No Abstract]   [Full Text] [Related]  

  • 57. [CORRELATION BETWEEN LATENT DIABETES, OBESITY AND FATTY LIVER].
    KNICK B; LANGE HJ; HECKMANN K
    Dtsch Med Wochenschr; 1965 Jul; 90():1286-9. PubMed ID: 14314999
    [No Abstract]   [Full Text] [Related]  

  • 58. Nicotinamide Phosphoribosyltransferase Knockdown Leads to Lipid Accumulation in HepG2 Cells through The SIRT1-AMPK Pathway.
    Ilbeigi D; Nourbakhsh M; Pasalar P; Meshkani R; Shokri Afra H; Panahi GH; Borji M; Sharifi R
    Cell J; 2020 Jul; 22(Suppl 1):125-132. PubMed ID: 32779442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease.
    Baker PR; Friedman JE
    J Clin Invest; 2018 Aug; 128(9):3692-3703. PubMed ID: 30168806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nicotinamide phosphoribosyltransferase in malignancy: a review.
    Shackelford RE; Mayhall K; Maxwell NM; Kandil E; Coppola D
    Genes Cancer; 2013 Nov; 4(11-12):447-56. PubMed ID: 24386506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.